Equally, the inhibition of PTP1B activity causes IM resistance, through an increase in kinase activity of BCR-ABL1 and blockage of the IM-induced effects in K562 and in SupB-15 (Ph+ ALL cell line). The gene discussed is BCR; the disease is acute lymphoblastic leukemia.